ClinicalTrials.govpublic full text
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder
major depressive disorder, psilocybin, mdd, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 906858
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.